Attached files

file filename
8-K/A - 8-K/A - Ventas, Inc.a15-18213_18ka.htm
EX-99.2 - EX-99.2 - Ventas, Inc.a15-18213_1ex99d2.htm
EX-99.1 - EX-99.1 - Ventas, Inc.a15-18213_1ex99d1.htm
EX-23.1 - EX-23.1 - Ventas, Inc.a15-18213_1ex23d1.htm

Exhibit 99.3

 

VENTAS, INC.

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

As of and For the Six Months Ended June 30, 2015 and For the Year Ended December 31, 2014

 

On August 4, 2015, Ventas completed its acquisition of Ardent Medical Services, Inc. (“AHS”).  Concurrent with the closing of the transaction, the Company separated AHS’s hospital operations from its owned real estate and sold the hospital operations to a newly formed and capitalized operating company (“Ardent”).  An entity controlled by Equity Group Investments acquired a majority stake in Ardent, while Ventas retained a 9.9 percent interest and AHS management retained a significant ownership stake.

 

Also, on August 17, 2015, Ventas, Inc. (“Ventas” or the “Company”), entered into a Separation and Distribution Agreement with Care Capital Properties, Inc. (“CCP”), pursuant to which the Company agreed to transfer most of its post-acute / skilled nursing facility portfolio to CCP and distribute all of the Company-owned common stock of CCP to the Company’s stockholders in a distribution intended to be tax-free to the Company’s stockholders (the “Distribution”). The Distribution was effective at 11:59 p.m., Eastern Time, on August 17, 2015 (the “Effective Time”) to the Company’s stockholders of record as of the close of business on August 10, 2015. As a result of the Distribution, CCP is now an independent public company and its common stock is listed under the symbol “CCP” on the New York Stock Exchange.

 

The following unaudited pro forma condensed consolidated financial information sets forth:

 

·             The historical consolidated financial information of Ventas as of and for the six months ended June 30, 2015, derived from Ventas’s unaudited consolidated financial statements, and the historical consolidated statement of income information of Ventas for the year ended December 31, 2014, derived from Ventas’s audited consolidated financial statements;

 

·             Pro forma adjustments to give effect of the spin-off of CCP on August 17, 2015 on Ventas’s consolidated balance sheet as of June 30, 2015, as if the spin-off occurred on June 30, 2015;

 

·             Pro forma adjustments to give effect of the AHS transaction on August 4, 2015 on Ventas’s consolidated balance sheet as of June 30, 2015, as if the transaction occurred on June 30, 2015;

 

·             Pro forma adjustments to give effect to Ventas’s other 2015 and 2014 transactions, including the 2015 acquisitions of American Realty Capital Healthcare Trust, Inc. (“HCT”) and 12 skilled nursing facilities, and other 2015 and 2014 significant debt activity, on Ventas’s consolidated statements of income for the six months ended June 30, 2015 and for the year ended December 31, 2014, as if these transactions occurred on January 1, 2014;

 

·             Pro forma adjustments to give effect of the spin-off of CCP on August 17, 2015 on Ventas’s consolidated statements of income for the six months ended June 30, 2015 and for the year ended December 31, 2014, as if the spin-off occurred on January 1, 2014; and

 

·             Pro forma adjustments to give effect of the AHS transaction on August 4, 2015 on Ventas’s consolidated statements of income for the six months ended June 30, 2015 and for the year ended December 31, 2014, as if the transaction occurred on January 1, 2014; and

 

These unaudited pro forma condensed consolidated financial statements have been prepared for informational purposes only and are based on assumptions and estimates considered appropriate by Ventas’s management; however, they are not necessarily indicative of what Ventas’s consolidated financial condition or results of operations actually would have been assuming the transactions had been consummated as of the dates indicated, nor do they purport to represent Ventas’s consolidated financial position or results of operations for future periods. These unaudited pro forma condensed consolidated

 



 

financial statements do not include the impact of any synergies that may be achieved in the transactions or any strategies that management may consider in order to continue to efficiently manage Ventas’s operations.  This pro forma condensed consolidated financial information should be read in conjunction with:

 

·             Ventas’s unaudited consolidated financial statements and the related notes thereto as of and for the six months ended June 30, 2015 included in the Company’s Quarterly Report on Form 10-Q for the quarter then ended, filed with the Securities and Exchange Commission (“SEC”) on July 27, 2015;

 



 

·             Ventas’s audited consolidated financial statements and the related notes thereto as of and for the year ended December 31, 2014 included in the Company’s Annual Report on Form 10-K for the year then ended, filed with the SEC on February 13, 2015;

 

·             CCP’s Predecessors combined consolidated financial statements and the related notes thereto as of and for the year ended December 31, 2014 included in its information statement on Form 10 filed with the SEC on July 30, 2015; and

 

·             The audited consolidated financial statements of AHS Medical Holdings LLC, the 100% parent company of AHS (“AHS Medical Holdings”), as of and for the year ended December 31, 2014, included in this Current Report on Form 8-K/A; and

 

·             The unaudited condensed consolidated financial statements of AHS Medical Holdings as of and for the six months ended June 30, 2015, included in this Current Report on Form 8-K/A.

 



 

VENTAS, INC.

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED BALANCE SHEET

As of June 30, 2015

(In thousands)

 

 

 

Ventas
Historical

 

CCP Spin-Off
Adjustments
(A)

 

Pro Forma
for CCP
Spin-Off
Adjustments

 

AHS Medical
Holdings LLC
Historical (B)

 

AHS

Transaction

Adjustments

(C)

 

 

Total Pro
Forma

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net real estate investments

 

$

22,239,965

 

$

(2,597,111

)

$

19,642,854

 

$

836,755

 

$

474,226

 

(D)

$

20,953,835

 

Cash and cash equivalents

 

60,532

 

206,584

 

267,116

 

193,624

 

(164,151

)

(E)

296,589

 

Escrow deposits and restricted cash

 

193,960

 

 

193,960

 

 

 

 

193,960

 

Deferred financing costs, net

 

68,284

 

(1,642

)

66,642

 

 

8,905

 

(F)

75,547

 

Other assets

 

1,712,421

 

(159,768

)

1,552,653

 

1,008,793

 

(982,511

)

(G)

1,578,935

 

Total assets

 

$

24,275,162

 

$

(2,551,937

)

$

21,723,225

 

$

2,039,172

 

$

(663,531

)

 

$

23,098,866

 

Liabilities and equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Senior notes payable and other debt

 

$

11,507,861

 

$

(1,059,680

)

$

10,448,181

 

$

870,451

 

$

529,549

 

(H)

$

11,848,181

 

Accrued interest

 

77,631

 

 

77,631

 

 

 

 

77,631

 

Accounts payable and other liabilities

 

1,026,359

 

(205,941

)

820,418

 

407,594

 

(399,691

)

(I)

828,321

 

Deferred income taxes

 

370,161

 

 

370,161

 

 

 

 

370,161

 

Total liabilities

 

12,982,012

 

(1,265,621

)

11,716,391

 

1,278,045

 

129,858

 

 

13,124,294

 

Redeemable OP unitholder and noncontrolling interests

 

199,404

 

 

199,404

 

378,922

 

(378,922

)

 

199,404

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Ventas stockholders’ equity

 

11,027,483

 

(1,281,556

)

9,745,927

 

343,825

 

(376,087

)

 

9,713,665

 

Noncontrolling interest

 

66,263

 

(4,760

)

61,503

 

38,380

 

(38,380

)

 

61,503

 

Total equity

 

11,093,746

 

(1,286,316

)

9,807,430

 

382,205

 

(414,467

)

 

9,775,168

 

Total liabilities and equity

 

$

24,275,162

 

$

(2,551,937

)

$

21,723,225

 

$

2,039,172

 

$

(663,531

)

 

$

23,098,866

 

 

See accompanying notes to unaudited pro forma condensed consolidated financial statements.

 



 

VENTAS, INC.

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF INCOME

For the Six Months Ended June 30, 2015

(In thousands, except per share amounts)

 

 

 

Ventas
Historical

 

Other 2015
Transactions (J)

 

Pro Forma for
Other 2015
Transactions

 

CCP Spin-Off
Adjustments (A)

 

Pro Forma for
Other 2015
Transactions
and CCP Spin-
Off Adjustments

 

AHS Medical
Holdings LLC
Historical (B)

 

AHS Transaction

Adjustments (K)

 

 

 

Total Pro Forma

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Rental income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Triple-net leased

 

$

526,768

 

$

2,816

 

$

529,584

 

$

(159,152

)

$

370,432

 

$

 

$

52,500

 

(L)

 

$

422,932

 

Medical office buildings

 

277,393

 

5,004

 

282,397

 

 

282,397

 

 

 

 

 

282,397

 

 

 

804,161

 

7,820

 

811,981

 

(159,152

)

652,829

 

 

52,500

 

 

 

705,329

 

Resident fees and services

 

901,559

 

6,402

 

907,961

 

 

907,961

 

982,599

 

(982,599

)

 

 

907,961

 

Medical office building and other services revenue

 

19,951

 

 

19,951

 

 

19,951

 

 

 

 

 

19,951

 

Income from loans and investments

 

48,967

 

37

 

49,004

 

(1,725

)

47,279

 

 

 

 

 

47,279

 

Interest and other income

 

708

 

 

708

 

(63

)

645

 

28,015

 

(28,015

)

 

 

645

 

Total revenues

 

1,775,346

 

14,259

 

1,789,605

 

(160,940

)

1,628,665

 

1,010,614

 

(958,114

)

 

 

1,681,165

 

Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest

 

214,181

 

(3,774

)

210,407

 

(12,463

)

197,944

 

38,129

 

(21,791

)

(M)

 

214,282

 

Depreciation and amortization

 

496,636

 

14,430

 

511,066

 

(67,192

)

443,874

 

42,775

 

(25,028

)

(N)

 

461,621

 

Property-level operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Senior living

 

597,614

 

4,826

 

602,440

 

 

602,440

 

887,613

 

(887,613

)

 

 

602,440

 

Medical office buildings

 

85,670

 

883

 

86,553

 

 

86,553

 

 

 

 

 

86,553

 

 

 

683,284

 

5,709

 

688,993

 

 

688,993

 

887,613

 

(887,613

)

 

 

688,993

 

Medical office building services costs

 

12,682

 

 

12,682

 

 

12,682

 

 

 

 

 

12,682

 

General, administrative and professional fees

 

68,292

 

3,364

 

71,656

 

(5,000

)

66,656

 

 

 

 

 

66,656

 

Gain on extinguishment of debt, net

 

(434

)

 

(434

)

 

(434

)

 

 

 

 

(434

)

Merger-related expenses and deal costs

 

49,757

 

 

49,757

 

(3,755

)

46,002

 

 

 

 

 

46,002

 

Other

 

10,387

 

 

10,387

 

(1,019

)

9,368

 

 

 

 

 

9,368

 

Total expenses

 

1,534,785

 

19,729

 

1,554,514

 

(89,429

)

1,465,085

 

968,517

 

(934,432

)

 

 

1,499,170

 

Income (loss) before loss from unconsolidated entities, income taxes, discontinued operations, real estate dispositions and noncontrolling interest

 

240,561

 

(5,470

)

235,091

 

(71,511

)

163,580

 

42,097

 

(23,682

)

 

 

181,995

 

(Loss) income from unconsolidated entities

 

(242

)

 

(242

)

 

(242

)

 

1,500

 

(O)

 

1,258

 

Income tax benefit

 

17,039

 

2,262

 

19,301

 

 

19,301

 

(10,127

)

10,127

 

 

 

19,301

 

Income (loss) from continuing operations

 

257,358

 

(3,208

)

254,150

 

(71,511

)

182,639

 

31,970

 

(12,055

)

 

 

202,554

 

Gain on real estate dispositions

 

14,155

 

 

14,155

 

 

14,155

 

2,491

 

(2,491

)

 

 

14,155

 

Income (loss) from continuing operations, including real estate dispositions

 

271,513

 

(3,208

)

268,305

 

(71,511

)

196,794

 

34,461

 

(14,546

)

 

 

216,709

 

Net income (loss) attributable to noncontrolling interest

 

894

 

 

894

 

(112

)

782

 

21,419

 

(21,419

)

 

 

782

 

Income (loss) from continuing operations attributable to common stockholders, including real estate dispositions

 

$

270,619

 

$

(3,208

)

$

267,411

 

$

(71,399

)

$

196,012

 

$

13,042

 

$

6,873

 

 

 

$

215,927

 

Income from continuing operations attributable to common stockholders per common share, including real estate dispositions:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.82

 

N/A

 

$

0.81

 

N/A

 

$

0.59

 

N/A

 

N/A

 

 

 

$

0.65

 

Diluted

 

$

0.82

 

N/A

 

$

0.81

 

N/A

 

$

0.59

 

N/A

 

N/A

 

 

 

$

0.65

 

Weighted average shares used in computing earnings per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

327,890

 

N/A

 

327,890

 

N/A

 

327,890

 

N/A

 

N/A

 

 

 

327,890

 

Diluted

 

331,424

 

N/A

 

331,424

 

N/A

 

331,424

 

N/A

 

N/A

 

 

 

331,424

 

 

See accompanying notes to unaudited pro forma condensed consolidated financial statements.

 



 

VENTAS, INC.

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF INCOME

For the Year Ended December 31, 2014

(In thousands, except per share amounts)

 

 

 

Ventas
Historical

 

Other 2015 and
2014
Transactions (J)

 

Pro Forma for
Other 2015 and
2014
Transactions

 

CCP Spin-Off
Adjustments (A)

 

Pro Forma for
Other 2015 and
2014 Transactions
and CCP Spin-
Off Adjustments

 

AHS Medical
Holdings LLC
Historical (B)

 

AHS

Transaction

Adjustments (K)

 

 

 

Total Pro
Forma

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Rental income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Triple-net leased

 

$

970,377

 

$

44,987

 

$

1,015,364

 

$

(327,490

)

$

687,874

 

$

 

$

105,000

 

(L)

 

$

792,874

 

Medical office buildings

 

463,618

 

110,167

 

573,785

 

 

573,785

 

 

 

 

 

573,785

 

 

 

1,433,995

 

155,154

 

1,589,149

 

(327,490

)

1,261,659

 

 

105,000

 

 

 

1,366,659

 

Resident fees and services

 

1,552,951

 

155,454

 

1,708,405

 

 

1,708,405

 

1,760,021

 

(1,760,021

)

 

 

1,708,405

 

Medical office building and other services revenue

 

29,364

 

 

29,364

 

2,500

 

31,864

 

 

 

 

 

31,864

 

Income from loans and investments

 

55,169

 

880

 

56,049

 

(3,400

)

52,649

 

 

 

 

 

52,649

 

Interest and other income

 

4,267

 

11

 

4,278

 

(2

)

4,276

 

266,847

 

(266,847

)

 

 

4,276

 

Total revenues

 

3,075,746

 

311,499

 

3,387,245

 

(328,392

)

3,058,853

 

2,026,868

 

(1,921,868

)

 

 

3,163,853

 

Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest

 

376,842

 

53,568

 

430,410

 

(24,895

)

405,515

 

87,170

 

(54,964

)

(M)

 

437,721

 

Depreciation and amortization

 

826,911

 

167,115

 

994,026

 

(116,953

)

877,073

 

103,253

 

(67,759

)

(N)

 

912,567

 

Property-level operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Senior living

 

1,036,556

 

105,736

 

1,142,292

 

 

1,142,292

 

1,831,365

 

(1,831,365

)

 

 

1,142,292

 

Medical office buildings

 

158,542

 

20,939

 

179,481

 

 

179,481

 

 

 

 

 

179,481

 

 

 

1,195,098

 

126,675

 

1,321,773

 

 

1,321,773

 

1,831,365

 

(1,831,365

)

 

 

1,321,773

 

Medical office building services costs

 

17,092

 

 

17,092

 

 

17,092

 

 

 

 

 

17,092

 

General, administrative and professional fees

 

121,746

 

11,756

 

133,502

 

(10,000

)

123,502

 

 

 

 

 

123,502

 

Loss on extinguishment of debt, net

 

5,564

 

 

5,564

 

6,881

 

12,445

 

 

 

 

 

12,445

 

Merger-related expenses and deal costs

 

45,051

 

 

45,051

 

(1,547

)

43,504

 

 

32,262

 

(P)

 

75,766

 

Other

 

38,925

 

 

38,925

 

(13,183

)

25,742

 

 

 

 

 

25,742

 

Total expenses

 

2,627,229

 

359,114

 

2,986,343

 

(159,697

)

2,826,646

 

2,021,788

 

(1,921,826

)

 

 

2,926,608

 

Income (loss) before loss from unconsolidated entities, income taxes, discontinued operations, real estate dispositions and noncontrolling interest

 

448,517

 

(47,615

)

400,902

 

(168,695

)

232,207

 

5,080

 

(42

)

 

 

237,245

 

(Loss) income from unconsolidated entities

 

(139

)

 

(139

)

 

(139

)

 

3,000

 

(O)

 

2,861

 

Income tax benefit

 

8,732

 

21,409

 

30,141

 

 

30,141

 

62,517

 

(62,517

)

 

 

30,141

 

Income (loss) from continuing operations

 

457,110

 

(26,206

)

430,904

 

(168,695

)

262,209

 

67,597

 

(59,559

)

 

 

270,247

 

Gain on real estate dispositions

 

17,970

 

 

17,970

 

61

 

18,031

 

148,962

 

(148,962

)

 

 

18,031

 

Income (loss) from continuing operations, including real estate dispositions

 

475,080

 

(26,206

)

448,874

 

(168,634

)

280,240

 

216,559

 

(208,521

)

 

 

288,278

 

Net income (loss) attributable to noncontrolling interest

 

1,419

 

 

1,419

 

(185

)

1,234

 

39,302

 

(39,302

)

 

 

1,234

 

Income (loss) from continuing operations attributable to common stockholders

 

$

473,661

 

$

(26,206

)

$

447,455

 

$

(168,449

)

$

279,006

 

$

177,257

 

$

(169,219

)

 

 

$

287,044

 

Income (loss) from continuing operations attributable to common stockholders per common share, including real estate dispositions:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

1.61

 

N/A

 

$

1.39

 

N/A

 

$

0.86

 

N/A

 

N/A

 

 

 

$

0.89

 

Diluted

 

$

1.59

 

N/A

 

$

1.37

 

N/A

 

$

0.86

 

N/A

 

N/A

 

 

 

$

0.88

 

Weighted average shares used in computing earnings per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

294,175

 

28,415

 

322,590

 

N/A

 

322,590

 

N/A

 

N/A

 

 

 

322,590

 

Diluted

 

296,677

 

29,533

 

326,210

 

N/A

 

326,210

 

N/A

 

N/A

 

 

 

326,210

 

 

See accompanying notes to unaudited pro forma condensed consolidated financial statements.

 



 

VENTAS, INC.

NOTES AND MANAGEMENT’S ASSUMPTIONS TO UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 1 - BASIS OF PRO FORMA PRESENTATION

 

Ventas, Inc. (“Ventas” or the “Company”) is a real estate investment trust (“REIT”) with a geographically diverse portfolio of seniors housing and healthcare properties in the United States, Canada and the United Kingdom.  The historical consolidated financial statements of Ventas include the accounts of the Company and its wholly owned subsidiaries and joint venture entities over which it exercises control.

 

On August 4, 2015, Ventas completed its acquisition of Ardent Medical Services, Inc. (“AHS”).  Concurrent with the closing of the transaction, the Company separated AHS’s hospital operations from its owned real estate and sold the hospital operations to a newly formed and capitalized operating company (“Ardent”).  An entity controlled by Equity Group Investments acquired a majority stake in Ardent, while Ventas retained a 9.9 percent interest and AHS management retained a significant ownership stake.

 

Also, on August 17, 2015, Ventas, Inc. (“Ventas” or the “Company”), entered into a Separation and Distribution Agreement with Care Capital Properties, Inc. (“CCP”), pursuant to which the Company agreed to transfer most of its post-acute / skilled nursing facility portfolio to CCP and distribute all of the Company-owned common stock of CCP to the Company’s stockholders in a distribution intended to be tax-free to the Company’s stockholders (the “Distribution”). The Distribution was effective at 11:59 p.m., Eastern Time, on August 17, 2015 (the “Effective Time”) to the Company’s stockholders of record as of the close of business on August 10, 2015. As a result of the Distribution, CCP is now an independent public company and its common stock is listed under the symbol “CCP” on the New York Stock Exchange.

 

NOTE 2 - ADJUSTMENTS TO UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

(A)  Reflects the financial statement effects of the spin-off of CCP on August 17, 2015.  Adjustments also reflect the financial statement effects of the transition services arrangement entered into with CCP, a $1.3 billion distribution received by Ventas from CCP and the repayment of $1.1 billion of Ventas indebtedness and related fees.

 

(B) Reflects unaudited historical financial condition and results of operations of AHS Medical Holdings LLC, the 100% parent company of AHS (“AHS Medical Holdings”), as of and for the six months ended June 30, 2015 and the audited historical results of operations of AHS Medical Holdings for the year ended December 31, 2014.  Certain amounts have been reclassified to conform to Ventas’s presentation, including the classification of patient service revenue as resident fees and services, the classification of all operating expenses as senior living property-level operating expenses, the classification of accrued preferred dividends as net income (loss) from noncontrolling interest and the classification of certain noncontrolling interests and redeemable preferred units and accrued dividends as redeemable OP unitholder and noncontrolling interests.

 

(C)  Reflects adjustments to record the acquisition date fair value of the real estate acquired from AHS.  Also, adjustments reflect the elimination of all operating assets and liabilities now owned by Ardent, including senior notes payable and other debt and noncontrolling interest.

 



 

(D)  Reflects the increase over AHS Medical Holdings’s historical investment in real estate based upon Ventas’s initial estimate of the acquisition date fair value for the acquired tangible and intangible real estate assets.  These initial values are as follows (in millions):

 

Land and improvements

 

$

97

 

Buildings and improvements

 

1,137

 

Acquired lease intangibles

 

77

 

Initial fair value of net real estate investments

 

$

1,311

 

 

(E)        Reflects the issuance in July 2015 of $500.0 million aggregate principal amount of 4.125% senior notes due 2026 and proceeds from an August 2015 $900.0 million five year variable rate term loan, partially offset by $1.4 billion of cash paid at closing of the AHS transaction.

 

(F)         Reflects the payment of deferred financing costs related to the July 2015 senior note issuance and the August 2015 term loan proceeds.

 

(G)       Reflects the value of Ventas’s 9.9% ownership interest in Ardent.

 

(H)      Reflects the issuance in July 2015 of $500.0 million aggregate principal amount of 4.125% senior notes due 2026 and proceeds from an August 2015 $900.0 million five year term loan, partially offset by the elimination of $870.5 million of AHS Medical Holdings LLC debt not assumed as part of the transaction.

 

(I)  Reflects certain opening balance sheet liabilities of $7.9 million related to the real estate assets acquired as part of the AHS transaction.

 

(J)           Adjustments reflect the financial statement effects of Ventas’s January 2015 acquisitions of American Realty Capital Healthcare Trust, Inc. (“HCT”) and 12 skilled nursing facilities, of which certain HCT properties and all 12 skilled nursing facilities were included in the spin-off of CCP on August 17, 2015.  Adjustments also reflect the Company’s senior note debt issuances and maturities during the six months ended June 30, 2015 and the year ended December 31, 2014, as if those transactions were consummated on January 1, 2014.

 

The adjustment to general, administrative and professional fees reflects the actual savings that Ventas expects to realize after the spin-off, which is lower than its allocation of historical expenses to CCP, due to costs related to corporate functions that both CCP and Ventas will incur as independent publicly traded companies, such as executive oversight, treasury, finance, legal, human resources, tax planning, internal audit, financial reporting, information technology and investor relations.

 

(K)       Reflects adjustments to record the income statement effect of the AHS transaction. Also, adjustments reflect the elimination of all income and expense items related to AHS Medical Holdings LLC, the 100% parent company of AHS.

 

(L)        Adjustment reflects $105.0 million annual rental income to be received relating to the leases of the AHS real estate.

 

(M)    Adjustments reflect the financial statement effects of Ventas’s issuance in July 2015 of $500.0 million aggregate principal amount of 4.125% senior notes due 2026 and an August 2015 $900.0 million five year variable rate term loan.

 



 

AHS Acquisition Adjustments

 

(N)       Based on its initial estimate of the acquisition date fair values of real estate from the AHS transaction, Ventas expects to record the following fair values to the asset classes: $97 million to land and improvements, $1.1 billion to buildings and improvements, and $77 million to acquired in-place lease intangibles. Depreciation expense is calculated on a straight-line basis based on Ventas’s fair value determinations and its estimates of the remaining useful lives of each asset.  The adjustment to depreciation and amortization reflects the following components (in thousands):

 

 

 

Weighted
Average
Useful Life
(Years)

 

For the Six Months
Ended June 30,
2015

 

For the Year Ended
December 31, 2014

 

Ventas’s AHS acquisition adjustments for depreciation and amortization, by asset type:

 

 

 

 

 

 

 

Land improvements

 

9

 

$

961

 

$

1,922

 

Building and improvements

 

40

 

15,473

 

30,947

 

In-place lease intangibles

 

30

 

1,313

 

2,625

 

Adjustment for depreciation and amortization

 

 

 

$

17,747

 

$

35,494

 

 

(O)       Adjustment reflects the estimate of Ventas’s proportionate share of net income from its 9.9% ownership interest in Ardent.

 

(P)         Reflects the payment of certain merger related expenses and deal costs at the time of the closing of the AHS transaction.

 



 

NOTE 3 - FUNDS FROM OPERATIONS AND NORMALIZED FUNDS FROM OPERATIONS

 

VENTAS, INC.

UNAUDITED PRO FORMA FFO AND NORMALIZED FFO

For the Six Months Ended June 30, 2015

(In thousands, except per share amounts)

 

 

 

Ventas
Historical

 

Other 2015
Transactions

 

Pro Forma
for Other
2015
Transactions

 

CCP Spin-
Off
Adjustments

 

Pro Forma
for Other
2015
Transactions
and CCP
Spin-Off
Adjustments

 

AHS Medical
Holdings
Historical

 

AHS
Acquisition
Adjustments

 

Total Pro
Forma

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from continuing operations attributable to common stockholders, including real estate dispositions

 

$

270,619

 

$

(3,208

)

$

267,411

 

$

(71,399

)

$

196,012

 

$

13,042

 

$

6,873

 

$

215,927

 

Discontinued operations

 

(356

)

 

(356

)

 

(356

)

(9

)

9

 

(356

)

Net income (loss) attributable to common stockholders

 

270,263

 

(3,208

)

267,055

 

(71,399

)

195,656

 

13,033

 

6,882

 

215,571

 

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Real estate depreciation and amortization

 

493,043

 

14,430

 

507,473

 

(67,192

)

440,281

 

42,775

 

(25,028

)

458,028

 

Real estate depreciation related to noncontrolling interest

 

(4,016

)

 

(4,016

)

134

 

(3,882

)

 

 

(3,882

)

Real estate depreciation related to unconsolidated entities

 

2,926

 

 

2,926

 

 

2,926

 

 

 

2,926

 

Gain on real estate dispositions

 

(14,155

)

 

(14,155

)

 

(14,155

)

(2,491

)

2,491

 

(14,155

)

Discontinued operations:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gain on real estate dispositions

 

(277

)

 

(277

)

 

(277

)

 

 

(277

)

Depreciation on real estate assets

 

24

 

 

24

 

 

24

 

 

 

24

 

FFO

 

747,808

 

11,222

 

759,030

 

(138,457

)

620,573

 

53,317

 

(15,655

)

658,235

 

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change in fair value of financial instruments

 

24

 

 

24

 

 

24

 

 

 

24

 

Non-cash income tax benefit

 

(18,239

)

(2,262

)

(20,501

)

 

(20,501

)

 

 

(20,501

)

Gain on extinguishment of debt, net

 

(18

)

 

(18

)

 

(18

)

 

 

(18

)

Merger-related expenses, deal costs and re-audit costs

 

51,137

 

 

51,137

 

(3,755

)

47,382

 

 

 

47,382

 

Amortization of other intangibles

 

1,182

 

 

1,182

 

 

1,182

 

 

 

1,182

 

Normalized FFO

 

$

781,894

 

$

8,960

 

$

790,854

 

$

(142,212

)

$

648,642

 

$

53,317

 

$

(15,655

)

$

686,304

 

 



 

 

 

Ventas
Historical

 

Total Pro
Forma

 

 

 

 

 

 

 

Income from continuing operations attributable to common stockholders, including real estate dispositions

 

$

0.82

 

$

0.65

 

Discontinued operations

 

(0.00

)

(0.00

)

Net income attributable to common stockholders

 

0.82

 

0.65

 

Adjustments:

 

 

 

 

 

Real estate depreciation and amortization

 

1.49

 

1.38

 

Real estate depreciation related to noncontrolling interest

 

(0.01

)

(0.01

)

Real estate depreciation related to unconsolidated entities

 

0.01

 

0.01

 

Gain on real estate dispositions

 

(0.04

)

(0.04

)

Discontinued operations:

 

 

 

 

 

Gain on real estate dispositions

 

(0.00

)

(0.00

)

Depreciation on real estate assets

 

0.00

 

0.00

 

FFO

 

2.26

 

1.99

 

Adjustments:

 

 

 

 

 

Change in fair value of financial instruments

 

0.00

 

0.00

 

Non-cash income tax benefit

 

(0.06

)

(0.06

)

Gain on extinguishment of debt, net

 

(0.00

)

(0.00

)

Merger-related expenses, deal costs and re-audit costs

 

0.15

 

0.14

 

Amortization of other intangibles

 

0.00

 

0.00

 

Normalized FFO

 

$

2.36

 

$

2.07

 

 

 

 

 

 

 

Dilutive shares outstanding used in computing FFO and normalized FFO per common share

 

331,424

 

331,424

 

 


(1) Per share amounts may not add due to rounding.

 



 

VENTAS, INC.

UNAUDITED PRO FORMA FFO AND NORMALIZED FFO

For the Year Ended December 31, 2014

(In thousands, except per share amounts)

 

 

 

Ventas
Historical

 

Other 2015
and 2014
Transactions

 

Pro Forma
for Other
2015 and
2014
Transactions

 

CCP Spin-
Off
Adjustments

 

Pro Forma
for Other
2015 and
2014
Transactions
and CCP
Spin-Off
Adjustments

 

AHS Medical
Holdings
Historical

 

AHS
Acquisition
Adjustments

 

Total Pro
Forma

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from continuing operations attributable to common stockholders, including real estate dispositions

 

$

473,661

 

$

(26,206

)

$

447,455

 

$

(168,449

)

$

279,006

 

$

177,257

 

$

(169,219

)

$

287,044

 

Discontinued operations

 

2,106

 

 

2,106

 

 

2,106

 

(293

)

293

 

2,106

 

Net income (loss) attributable to common stockholders

 

475,767

 

(26,206

)

449,561

 

(168,449

)

281,112

 

176,964

 

(168,926

)

289,150

 

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Real estate depreciation and amortization

 

820,344

 

167,115

 

987,459

 

(116,953

)

870,506

 

103,253

 

(67,759

)

906,000

 

Real estate depreciation related to noncontrolling interest

 

(10,314

)

 

(10,314

)

427

 

(9,887

)

 

 

(9,887

)

Real estate depreciation related to unconsolidated entities

 

5,792

 

 

5,792

 

 

5,792

 

 

 

5,792

 

Gain on real estate dispositions

 

(17,970

)

 

(17,970

)

(61

)

(18,031

)

(148,962

)

148,962

 

(18,031

)

Discontinued operations:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gain on real estate dispositions

 

(1,494

)

 

(1,494

)

 

(1,494

)

 

 

(1,494

)

Depreciation on real estate assets

 

1,555

 

 

1,555

 

 

1,555

 

 

 

1,555

 

FFO

 

1,273,680

 

140,909

 

1,414,589

 

(285,036

)

1,129,553

 

131,255

 

(87,723

)

1,173,085

 

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change in fair value of financial instruments

 

5,121

 

 

5,121

 

 

5,121

 

 

 

5,121

 

Non-cash income tax benefit

 

(9,431

)

(21,409

)

(30,840

)

 

(30,840

)

 

 

(30,840

)

Loss on extinguishment of debt, net

 

5,013

 

 

5,013

 

 

5,013

 

 

 

5,013

 

Merger-related expenses, deal costs and re-audit fees

 

54,389

 

 

54,389

 

(1,547

)

52,842

 

 

32,262

 

85,104

 

Amortization of other intangibles

 

1,246

 

 

1,246

 

 

1,246

 

 

 

1,246

 

Normalized FFO

 

$

1,330,018

 

$

119,500

 

$

1,449,518

 

$

(286,583

)

$

1,162,935

 

$

131,255

 

$

(55,461

)

$

1,238,729

 

 



 

 

 

Ventas
Historical

 

Total Pro
Forma

 

 

 

 

 

 

 

Income from continuing operations attributable to common stockholders, including real estate dispositions

 

$

1.59

 

$

0.88

 

Discontinued operations

 

0.01

 

0.01

 

Net income attributable to common stockholders

 

1.60

 

0.89

 

Adjustments:

 

 

 

 

 

Real estate depreciation and amortization

 

2.77

 

2.78

 

Real estate depreciation related to noncontrolling interest

 

(0.03

)

(0.03

)

Real estate depreciation related to unconsolidated entities

 

0.02

 

0.02

 

Gain on real estate dispositions

 

(0.06

)

(0.06

)

Discontinued operations:

 

 

 

 

 

Gain on real estate dispositions

 

(0.01

)

(0.00

)

Depreciation on real estate assets

 

0.01

 

0.00

 

FFO

 

4.29

 

3.60

 

Adjustments:

 

 

 

 

 

Change in fair value of financial instruments

 

0.02

 

0.02

 

Non-cash income tax benefit

 

(0.03

)

(0.09

)

Loss on extinguishment of debt, net

 

0.02

 

0.02

 

Merger-related expenses, deal costs and re-audit costs

 

0.18

 

0.26

 

Amortization of other intangibles

 

0.00

 

0.00

 

Normalized FFO

 

$

4.48

 

$

3.80

 

 

 

 

 

 

 

Dilutive shares outstanding used in computing FFO and normalized FFO per common share

 

296,677

 

326,210

 

 


(1) Per share amounts may not add due to rounding.

 



 

Unaudited pro forma Funds From Operations (“FFO”) and normalized FFO are presented herein for informational purposes only and are based on available information and assumptions that the Company’s management believes to be reasonable; however, they are not necessarily indicative of what Ventas’s FFO or normalized FFO actually would have been assuming the transactions had occurred as of the dates indicated.

 

Historical cost accounting for real estate assets implicitly assumes that the value of real estate assets diminishes predictably over time.  However, since real estate values historically have risen or fallen with market conditions, many industry investors deem presentations of operating results for real estate companies that use historical cost accounting to be insufficient by themselves.  To overcome this problem, Ventas considers FFO and normalized FFO to be appropriate measures of operating performance of an equity REIT.  In particular, Ventas believes that normalized FFO is useful because it allows investors, analysts and Ventas management to compare Ventas’s operating performance to the operating performance of other real estate companies and between periods on a consistent basis without having to account for differences caused by unanticipated items and other events such as transactions and litigation.  In some cases, Ventas provides information about identified non-cash components of FFO and normalized FFO because it allows investors, analysts and Ventas management to assess the impact of those items on Ventas’s financial results.

 

Ventas uses the National Association of Real Estate Investment Trusts (“NAREIT”) definition of FFO.  NAREIT defines FFO as net income (computed in accordance with GAAP), excluding gains (or losses) from sales of real estate property, including gain on re-measurement of equity method investments, and impairment write-downs of depreciable real estate, plus real estate depreciation and amortization, and after adjustments for unconsolidated partnerships and joint ventures.  Adjustments for unconsolidated partnerships and joint ventures will be calculated to reflect FFO on the same basis.  Ventas defines normalized FFO as FFO excluding the following income and expense items (which may be recurring in nature): (a) merger-related costs and expenses, including amortization of intangibles, transition and integration expenses, and deal costs and expenses, including expenses and recoveries relating to the Company’s acquisition lawsuits; (b) the impact of any expenses related to asset impairment and valuation allowances, the write-off of unamortized deferred financing fees, or additional costs, expenses, discounts, make-whole payments, penalties or premiums incurred as a result of early retirement or payment of the Company’s debt; (c) the non-cash effect of income tax benefits or expenses and derivative transactions that have non-cash mark-to-market impacts on the Company’s consolidated statements of income; (d) the impact of future acquisitions or divestitures (including pursuant to tenant options to purchase) and capital transactions; (e) the financial impact of contingent consideration, severance-related costs, charitable donations made to the Ventas Charitable Foundation, gains and losses for non-operational foreign currency hedge agreements and changes in the fair value of financial instruments; and (f) expenses related to the re-audit and re-review of the Company’s historical financial statements and related matters.

 

FFO and normalized FFO presented herein may not be identical to FFO and normalized FFO presented by other real estate companies due to the fact that not all real estate companies use the same definitions.  FFO and normalized FFO should not be considered as alternatives to net income (determined in accordance with GAAP) as indicators of Ventas’s financial performance or as alternatives to cash flow from operating activities (determined in accordance with GAAP) as measures of Ventas’s liquidity, nor is FFO and normalized FFO necessarily indicative of sufficient cash flow to fund all of Ventas’s needs.  Ventas believes that in order to facilitate a clear understanding of Ventas’s consolidated historical operating results, FFO and normalized FFO should be examined in conjunction with net income as presented in the unaudited pro forma condensed consolidated financial statements.